FDA Approves Test for Hematologic Cancer Detection

The FDA has authorized ClearLLabs Reagents to market its test for use with flow cytometry to detect hematologic cancers, including myeloproliferative disorders.

 Hematol News

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.